Advanced BioMedical Technologies, Inc. (ABMT)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0002 (-50.00%)
At close: Jan 8, 2026

ABMT Income Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jul '21 Oct '20 Oct '19 Oct '18 Oct '17 Oct '16
0.110.120.01---
Revenue Growth (YoY)
50.66%960.20%----
Cost of Revenue
0.030.050.01---
Gross Profit
0.080.070---
Selling, General & Admin
0.190.220.320.560.340.37
Research & Development
0.220.180.260.060.050.06
Operating Expenses
0.510.520.610.630.40.46
Operating Income
-0.42-0.45-0.6-0.63-0.4-0.46
Interest Expense
-0.31-0.33-0.33-0.3-0.26-0.25
Interest & Investment Income
000000
Other Non Operating Income (Expenses)
-0.010.1-0.02-0.02-0.03-0.01
Pretax Income
-0.75-0.67-0.95-0.95-0.69-0.72
Net Income
-0.75-0.67-0.95-0.95-0.69-0.72
Net Income to Common
-0.75-0.67-0.95-0.95-0.69-0.72
Shares Outstanding (Basic)
707070696867
Shares Outstanding (Diluted)
707070696867
Shares Change (YoY)
0.45%0.69%0.35%1.62%2.38%17.26%
EPS (Basic)
-0.01-0.01-0.01-0.01-0.01-0.01
EPS (Diluted)
-0.01-0.01-0.01-0.01-0.01-0.01
Free Cash Flow
-0.040.62-0.76-0.9-0.56-0.37
Free Cash Flow Per Share
-0.000.01-0.01-0.01-0.01-0.01
Gross Margin
74.32%58.07%34.84%---
Operating Margin
-385.79%-361.38%-5187.77%---
Profit Margin
-685.68%-543.75%-8139.49%---
Free Cash Flow Margin
-39.45%498.40%-6529.08%---
EBITDA
-0.41-0.43-0.58-0.62-0.39-0.43
D&A For EBITDA
0.010.020.020.020.010.03
EBIT
-0.42-0.45-0.6-0.63-0.4-0.46
Source: S&P Global Market Intelligence. Standard template. Financial Sources.